Clinical Trial Update: Observation of the Efficacy and Tolerance of Motens® (Lacidipine) in Patients With Essential Hypertension

View source ↗

Summary

A completed clinical trial update assessing Motens (lacidipine) for essential hypertension, reporting observed efficacy and tolerability/safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Motens (Lacidipine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hypertension | Status: COMPLETED